Evidence map›Paper›PMID 36498862›Full record

ArticleInternational journal of molecular sciences2022

Autoimmune Neutropenia and Immune-Dysregulation in a Patient Carrying a

Benedetta Chianucci, Alice Grossi, Gianluca Dell'Orso, Elena Palmisani, Marina Lanciotti, Paola Terranova, Filomena Pierri, Michela Lupia, Luca Arcuri, Marica Laurino and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Benedetta ChianucciHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0001-8607-4200
Alice GrossiGenetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-4570-3485
Gianluca Dell'OrsoHematopoietic Stem Cell Transplant Unit, Department of Hematology and Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-6555-7219
Elena PalmisaniHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Marina LanciottiHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Paola TerranovaHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Filomena PierriHematopoietic Stem Cell Transplant Unit, Department of Hematology and Oncology, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Michela LupiaHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Luca ArcuriHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0001-9516-9148
Marica LaurinoHematology and Cellular Therapy Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Isabella CeccheriniGenetics and Genomics of Rare Diseases, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0001-8732-1955
Fabian BeierDepartment of Hematology, Oncology, Hemostaseology, Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, 52047 Aachen, Germany.ORCID 0000-0002-3718-8217
Carlo DufourHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Francesca FioreddaHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.
Maurizio MianoHaematology Unit, IRCCS Istituto Giannina Gaslini, 16147 Genoa, Italy.ORCID 0000-0002-9816-1704
Istituto Giannina Gaslini · ITOspedale Policlinico San Martino · ITRWTH Aachen University · DE

Funding

5X1000 Gaslini 5XMILR19Italian Ministry of Health ("Ricerca Corrente 2021") NA
6 · The paper itself

Abstract

In recent years, the knowledge about the immune-mediated impairment of bone marrow precursors in immune-dysregulation and autoimmune disorders has increased. In addition, immune-dysregulation, secondary to marrow failure, has been reported as being, in some cases, the most evident and early sign of the disease and making the diagnosis of both groups of disorders challenging. Dyskeratosis congenita is a disorder characterized by premature telomere erosion, typically showing marrow failure, nail dystrophy and leukoplakia, although incomplete genetic penetrance and phenotypes with immune-dysregulation features have been described. We report on a previously healthy 17-year-old girl, with a cousin successfully treated for acute lymphoblastic leukemia, who presented with leukopenia and neutropenia. The diagnostic work-up showed positive anti-neutrophil antibodies, leading to the diagnosis of autoimmune neutropenia, a slightly low NK count and high TCR-αβ+-double-negative T-cells. A next-generation sequencing (NGS) analysis showed the 734C>A variant on exon 6 of the TINF2 gene, leading to the p.Ser245Tyr. The telomere length was short on the lymphocytes and granulocytes, suggesting the diagnosis of an atypical telomeropathy showing with immune-dysregulation. This case underlines the importance of an accurate diagnostic work-up of patients with immune-dysregulation, who should undergo NGS or whole exome sequencing to identify specific disorders that deserve targeted follow-up and treatment.

Indexed as

Dyskeratosis CongenitaNeutropeniaBone MarrowExonsHumansTelomereTelomere-Binding ProteinsTelomere-Binding ProteinsTINF2 protein, humanautoimmune neutropenia (AIN)bone marrow failure (BMF)dyskeratosis congenita (DC)immune-dysregulationnext generation sequencing (NGS)telomeropathy

Identifiers

PMID36498862
PMCPMC9738458
OpenAlexW4309570007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.